---
title: "Dexamfetamine - Narcolepsy"
sidebar: mydoc_sidebar
permalink: db01576-mesh-d009290-1.html
toc: false 
---


Path ID: `DB01576_MESH_D009290_1`
{% include image.html url="images/db01576-mesh-d009290-1.png" file="db01576-mesh-d009290-1.png" alt="db01576-mesh-d009290-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| <a href="https://identifiers.org/MESH:D003913">MESH:D003913 </a> | Dexamfetamine | Drug |
| <a href="https://identifiers.org/UniProt:P23975">UniProt:P23975 </a> | Sodium-dependent noradrenaline transporter | Protein |
| <a href="https://identifiers.org/GO:0051620">GO:0051620 </a> | Norepinephrine uptake | BiologicalProcess |
| <a href="https://identifiers.org/MESH:D009638">MESH:D009638 </a> | Norepinephrine | ChemicalSubstance |
| <a href="https://identifiers.org/UniProt:Q01959">UniProt:Q01959 </a> | Sodium-dependent dopamine transporter | Protein |
| <a href="https://identifiers.org/GO:0051583">GO:0051583 </a> | Dopamine uptake involved in synaptic transmission | BiologicalProcess |
| <a href="https://identifiers.org/MESH:D004298">MESH:D004298 </a> | Dopamine | ChemicalSubstance |
| <a href="https://identifiers.org/GO:0061527">GO:0061527 </a> | Dopamine secretion, neurotransmission | BiologicalProcess |
| <a href="https://identifiers.org/UniProt:Q05940">UniProt:Q05940 </a> | Synaptic vesicular amine transporter | Protein |
| <a href="https://identifiers.org/GO:0015842">GO:0015842 </a> | Aminergic neurotransmitter loading into synaptic vesicle | BiologicalProcess |
| <a href="https://identifiers.org/GO:0061533">GO:0061533 </a> | Norepinephrine secretion, neurotransmission | BiologicalProcess |
| <a href="https://identifiers.org/MESH:D009290">MESH:D009290 </a> | Narcolepsy | Disease |
|------------|------|---------|

## Relationships


NOTE: predicates are annotated in <a href="https://github.com/biolink/biolink-model/releases/tag/v1.3.0">Biolink Model (v1.3.0)</a>

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Dexamfetamine | DECREASES ACTIVITY OF | Sodium-Dependent Noradrenaline Transporter |
| Dexamfetamine | DECREASES ACTIVITY OF | Sodium-Dependent Dopamine Transporter |
| Dexamfetamine | DECREASES ACTIVITY OF | Synaptic Vesicular Amine Transporter |
| Sodium-Dependent Noradrenaline Transporter | POSITIVELY REGULATES | Norepinephrine Uptake |
| Norepinephrine Uptake | DECREASES ABUNDANCE OF | Norepinephrine |
| Sodium-Dependent Dopamine Transporter | POSITIVELY REGULATES | Dopamine Uptake Involved In Synaptic Transmission |
| Dopamine Uptake Involved In Synaptic Transmission | DECREASES ABUNDANCE OF | Dopamine |
| Dopamine | POSITIVELY CORRELATED WITH | Dopamine Secretion, Neurotransmission |
| Synaptic Vesicular Amine Transporter | POSITIVELY REGULATES | Aminergic Neurotransmitter Loading Into Synaptic Vesicle |
| Aminergic Neurotransmitter Loading Into Synaptic Vesicle | DECREASES ABUNDANCE OF | Dopamine |
| Aminergic Neurotransmitter Loading Into Synaptic Vesicle | DECREASES ABUNDANCE OF | Norepinephrine |
| Norepinephrine | POSITIVELY CORRELATED WITH | Norepinephrine Secretion, Neurotransmission |
| Dopamine | POSITIVELY CORRELATED WITH | Dopamine Secretion, Neurotransmission |
| Norepinephrine Secretion, Neurotransmission | TREATS | Narcolepsy |
| Dopamine Secretion, Neurotransmission | TREATS | Narcolepsy |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB01576](https://go.drugbank.com/drugs/DB01576)
